HETLIOZ

LIVE

Serial Number

88981892

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M. Torelli

First Use Date

Apr 15, 2014

Filing Date

Apr 1, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

HETLIOZ Trademark

Serial Number: 88981892 • Registration: 6442600

HETLIOZ is a trademark filed by Vanda Pharmaceuticals Inc. on April 1, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Vanda Pharmaceuticals Inc. (104 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Jayme M. Torelli

174 trademarks filed View all →

Correspondence Address

Jayme M. Torelli HOFFMAN WARNICK LLC

540 BROADWAY

4TH FLOOR

ALBANY, NY 12207

UNITED STATES

Trademark Details

Filing Date

April 1, 2019

Registration Date

August 3, 2021

First Use Anywhere

April 15, 2014

First Use in Commerce

April 15, 2014

Published for Opposition

December 17, 2019

Goods & Services

Pharmaceutical preparations, containing tasimelteon, for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations, containing tasimelteon, for use in the treatment of non-24 hour sleep-wake disorder; and pharmaceutical preparations containing tasimelteon for use in the treatment of circadian rhythm sleep disorders; pharmaceutical preparations containing tasimelteon for use in the treatment of Smith-Magenis Syndrome

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 3, 2026 REM1

REGISTERED-PRINCIPAL REGISTER

Aug 3, 2021 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jun 26, 2021 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jun 25, 2021 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Jun 3, 2021 SUPC

DIVISIONAL PROCESSING COMPLETE

Jun 3, 2021 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 1, 2021 AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 10, 2021 AITU

USE AMENDMENT FILED

Jan 25, 2021 IUAF

DIVISIONAL REQUEST RECEIVED

Jan 25, 2021 DRRR

TEAS REQUEST TO DIVIDE RECEIVED

Jan 25, 2021 ERTD

TEAS STATEMENT OF USE RECEIVED

Jan 25, 2021 EISU

ASSIGNED TO EXAMINER

Oct 20, 2020 DOCK

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 18, 2020 EXRA

SOU EXTENSION 1 GRANTED

Jul 16, 2020 EX1G

SOU EXTENSION 1 FILED

Jul 16, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Jul 16, 2020 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 11, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 17, 2019 NPUB

PUBLISHED FOR OPPOSITION

Dec 17, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 27, 2019 NONP

ASSIGNED TO LIE

Nov 12, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 6, 2019 CNSA

EXAMINER'S AMENDMENT ENTERED

Nov 6, 2019 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 6, 2019 GNEN

EXAMINERS AMENDMENT E-MAILED

Nov 6, 2019 GNEA

EXAMINERS AMENDMENT -WRITTEN

Nov 6, 2019 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 12, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jun 12, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jun 12, 2019 CNRT

ASSIGNED TO EXAMINER

Jun 11, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 19, 2019 NWOS

NEW APPLICATION ENTERED

Apr 4, 2019 NWAP

Related Trademarks

More from this Owner

NEREUS 85MG (TRADIPITANT) CAPSULES

NEREUS (TRADIPITANT)

NEREUS (TRADIPITANT) CAPSULES

Serial #99839209

DELOSRX

QUIMILZA

More in Same Class

PEAK POWER MUSHROOM COMPLEX

SIBNAYAL